Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Indraprastha Medical Corporation Ltd.

Hospital & Healthcare Services

Rating :

N/A

BSE: 532150 | NSE: INDRAMEDCO

Watchlist

NSE BSE

490.30

20-Dec-2024

Open
High
Low
Previous Close

506.55
506.55
485.95
502.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

179696
891.34
529.90
154.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,484.64
30.35
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,175.29
0.92%
8.55

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.71
8.42
11.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.58
17.48
11.09

PAT CAGR (%)

10 Years
5 Years
3 Years

14.33
23.23
28.35

P:E (Median)

8 Years
5 Years
3 Years

14.17
11.06
12.74

P:BV (Average)

8 Years
5 Years
3 Years

2.95
2.95
3.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.96
9.01
7.50

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 13.52
P/E Ratio 32.35
Revenue 1245
EBITDA 193
Net Income 124
ROA 19.4
P/Bk Ratio 8.39
ROE 28.92
FCFF 142.02
FCFF Yield 3.77

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 349.82 317.00 10.35% 347.86 306.51 13.49% 314.73 274.05 14.84% 306.46 276.93 10.66%
Expenses 286.18 266.64 7.33% 280.74 259.25 8.29% 266.29 240.91 10.54% 259.16 239.87 8.04%
EBITDA 63.64 50.36 26.37% 67.12 47.26 42.02% 48.44 33.14 46.17% 47.30 37.06 27.63%
EBIDTM 18.19% 15.89% 19.30% 15.42% 15.39% 12.09% 15.43% 13.38%
Other Income 6.05 4.17 45.08% 5.12 3.56 43.82% 4.89 4.79 2.09% 4.27 3.08 38.64%
Interest 1.59 0.85 87.06% 1.61 0.78 106.41% 1.56 0.87 79.31% 0.87 0.87 0.00%
Depreciation 11.17 10.03 11.37% 11.04 9.81 12.54% 10.21 9.86 3.55% 10.03 9.86 1.72%
PBT 56.93 43.65 30.42% 59.59 40.23 48.12% 41.56 27.20 52.79% 40.67 29.41 38.29%
Tax 14.53 10.80 34.54% 14.82 9.73 52.31% 10.39 7.36 41.17% 11.23 8.51 31.96%
PAT 42.40 32.85 29.07% 44.77 30.50 46.79% 31.17 19.84 57.11% 29.44 20.90 40.86%
PATM 12.12% 10.36% 12.87% 9.95% 9.90% 7.24% 9.61% 7.55%
EPS 4.62 3.58 29.05% 4.88 3.33 46.55% 3.40 2.16 57.41% 3.21 2.28 40.79%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,318.87 1,244.70 1,098.67 888.16 613.38 830.77 788.17 752.66 765.72 755.45 714.46 Net Sales Growth 12.29% 13.29% 23.70% 44.80% -26.17% 5.40% 4.72% -1.71% 1.36% 5.74% Cost Of Goods Sold 221.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 1,097.69 1,244.70 1,098.67 888.16 613.38 830.77 788.17 752.66 765.72 755.45 714.46 GP Margin 83.23% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 1,092.37 1,051.34 947.97 773.86 573.11 744.38 707.39 679.87 686.92 676.07 629.60 Power & Fuel Cost - 26.01 25.22 20.56 17.18 21.16 19.70 19.26 20.91 25.16 25.09 % Of Sales - 2.09% 2.30% 2.31% 2.80% 2.55% 2.50% 2.56% 2.73% 3.33% 3.51% Employee Cost - 261.61 246.70 213.92 197.71 213.93 200.21 194.01 190.26 181.56 155.80 % Of Sales - 21.02% 22.45% 24.09% 32.23% 25.75% 25.40% 25.78% 24.85% 24.03% 21.81% Manufacturing Exp. - 607.80 546.21 446.99 302.24 419.95 404.14 389.10 395.14 390.49 376.02 % Of Sales - 48.83% 49.72% 50.33% 49.27% 50.55% 51.28% 51.70% 51.60% 51.69% 52.63% General & Admin Exp. - 150.64 124.79 82.60 51.61 83.66 78.20 72.29 76.58 74.10 70.33 % Of Sales - 12.10% 11.36% 9.30% 8.41% 10.07% 9.92% 9.60% 10.00% 9.81% 9.84% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 5.28 5.05 9.79 4.37 5.68 5.14 5.21 4.03 4.77 0.00 % Of Sales - 0.42% 0.46% 1.10% 0.71% 0.68% 0.65% 0.69% 0.53% 0.63% 0.33% EBITDA 226.50 193.36 150.70 114.30 40.27 86.39 80.78 72.79 78.80 79.38 84.86 EBITDA Margin 17.17% 15.53% 13.72% 12.87% 6.57% 10.40% 10.25% 9.67% 10.29% 10.51% 11.88% Other Income 20.33 16.89 10.03 3.12 0.68 0.69 0.47 0.79 0.46 2.12 0.97 Interest 5.63 4.06 4.28 3.41 3.34 5.92 6.87 8.90 7.91 7.42 8.11 Depreciation 42.45 40.08 39.27 34.94 33.32 32.97 29.75 30.68 30.53 35.33 28.18 PBT 198.75 166.11 117.18 79.07 4.29 48.19 44.62 34.01 40.82 38.75 49.55 Tax 50.97 42.15 31.03 20.45 1.96 4.57 16.21 12.90 14.57 14.31 17.06 Tax Rate 25.65% 25.37% 26.48% 25.86% 45.69% 9.48% 36.33% 37.93% 35.69% 36.93% 34.43% PAT 147.78 123.96 86.15 58.62 2.33 43.62 28.41 21.10 26.25 24.43 32.49 PAT before Minority Interest 147.78 123.96 86.15 58.62 2.33 43.62 28.41 21.10 26.25 24.43 32.49 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.21% 9.96% 7.84% 6.60% 0.38% 5.25% 3.60% 2.80% 3.43% 3.23% 4.55% PAT Growth 41.97% 43.89% 46.96% 2,415.88% -94.66% 53.54% 34.64% -19.62% 7.45% -24.81% EPS 16.12 13.52 9.39 6.39 0.25 4.76 3.10 2.30 2.86 2.66 3.54

Description TTM Mar 14 Mar 13
Net Sales - 677.58 606.72 Net Sales Growth - 11.68% Cost Of Goods Sold - 0.00 0.00 Gross Profit - 677.58 606.72 GP Margin - 100% 100% Total Expenditure - 586.74 528.16 Power & Fuel Cost - 23.75 21.04 % Of Sales - 3.51% 3.47% Employee Cost - 141.79 126.60 % Of Sales - 20.93% 20.87% Manufacturing Exp. - 356.43 327.73 % Of Sales - 52.60% 54.02% General & Admin Exp. - 62.52 50.88 % Of Sales - 9.23% 8.39% Selling & Distn. Exp. - 0.00 0.00 % Of Sales - 0% 0% Miscellaneous Exp. - 2.26 1.92 % Of Sales - 0.33% 0.32% EBITDA - 90.84 78.56 EBITDA Margin - 13.41% 12.95% Other Income - 1.01 1.43 Interest - 9.55 8.62 Depreciation - 28.14 25.89 PBT - 54.15 45.48 Tax - 18.72 16.72 Tax Rate - 34.57% 36.76% PAT - 35.44 28.76 PAT before Minority Interest - 35.44 28.76 Minority Interest - 0.00 0.00 PAT Margin - 5.23% 4.74% PAT Growth - 23.23% EPS - 3.86 3.14

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 477.76 379.45 325.44 272.75 267.80 244.04 232.31 230.83 223.75 194.76 Share Capital 91.67 91.67 91.67 91.67 91.67 91.67 91.67 91.67 91.67 91.67 Total Reserves 386.09 287.78 233.77 181.08 176.13 152.36 140.64 139.15 132.08 103.09 Non-Current Liabilities 80.06 46.06 42.77 43.30 41.59 54.24 61.53 41.87 46.23 52.81 Secured Loans 0.00 0.00 0.00 0.00 0.00 15.00 21.00 0.00 2.50 10.83 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 27.19 24.42 15.31 13.76 11.27 9.82 8.73 8.70 6.97 6.91 Current Liabilities 165.42 129.63 93.50 115.90 139.60 124.09 138.43 185.74 190.52 193.99 Trade Payables 139.60 98.18 76.75 91.75 103.74 90.98 71.34 96.21 88.51 86.48 Other Current Liabilities 23.08 17.54 15.88 15.74 22.08 26.02 21.16 21.10 54.69 62.37 Short Term Borrowings 0.00 0.00 0.00 0.00 3.98 0.29 38.56 64.81 44.67 24.58 Short Term Provisions 2.74 13.91 0.87 8.41 9.81 6.80 7.37 3.63 2.65 20.56 Total Liabilities 723.24 555.14 461.71 431.95 448.99 422.37 432.27 458.44 460.50 441.56 Net Block 346.94 275.05 276.86 283.33 302.68 280.10 293.96 295.73 301.03 286.20 Gross Block 567.29 497.80 468.85 455.30 448.38 396.70 387.93 360.89 336.28 553.20 Accumulated Depreciation 220.35 222.75 191.99 171.97 145.71 116.60 93.96 65.16 35.25 261.81 Non Current Assets 415.26 332.06 304.28 290.52 307.52 286.81 299.37 300.50 308.31 292.77 Capital Work in Progress 0.47 2.53 0.00 3.33 0.00 1.26 0.00 0.00 2.60 2.54 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.27 8.16 4.40 3.82 4.83 5.41 5.10 4.46 4.68 3.77 Other Non Current Assets 61.58 46.32 23.02 0.04 0.02 0.05 0.31 0.31 0.00 0.27 Current Assets 307.98 223.08 157.43 141.43 141.47 135.55 132.90 157.94 152.18 148.78 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 7.53 8.45 9.99 8.74 12.07 8.32 9.12 9.95 9.55 12.47 Sundry Debtors 58.40 68.24 43.35 67.39 79.15 76.20 84.47 98.31 84.78 77.75 Cash & Bank 224.43 128.75 68.45 27.52 24.01 22.44 7.94 6.99 6.32 6.19 Other Current Assets 17.62 16.86 18.30 22.57 26.24 28.60 31.36 42.69 51.54 52.37 Short Term Loans & Adv. 0.97 0.78 17.34 15.21 7.60 5.49 8.91 20.36 40.75 7.06 Net Current Assets 142.56 93.45 63.93 25.53 1.87 11.46 -5.53 -27.80 -38.33 -45.21 Total Assets 723.24 555.14 461.71 431.95 448.99 422.36 432.27 458.44 460.49 441.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 200.15 144.47 94.30 26.81 86.45 75.19 47.70 27.64 62.26 64.30 PBT 166.11 117.18 79.07 4.29 48.19 44.62 34.01 40.82 38.75 49.55 Adjustment 25.42 30.57 38.20 34.16 35.41 33.71 36.85 35.43 40.40 33.26 Changes in Working Capital 55.46 6.66 -3.45 -2.27 15.50 13.29 -6.64 -26.83 6.89 1.62 Cash after chg. in Working capital 246.99 154.41 113.82 36.18 99.10 91.63 64.22 49.42 86.03 84.43 Interest Paid -0.01 -0.09 -0.01 0.00 -0.08 -0.93 -3.69 -4.11 -2.39 -1.37 Tax Paid -46.83 -9.85 -19.51 -9.37 -12.57 -15.51 -12.83 -17.67 -21.38 -18.76 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -158.43 -107.91 -74.11 -19.08 -40.19 -16.70 -29.90 -22.40 -32.69 -29.14 Net Fixed Assets -67.43 -31.48 -10.22 -10.25 -50.42 -10.03 -27.04 -22.01 216.86 -28.87 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -91.00 -76.43 -63.89 -8.83 10.23 -6.67 -2.86 -0.39 -249.55 -0.27 Cash from Financing Activity -32.38 -26.04 -3.37 -3.14 -42.74 -44.18 -17.22 -5.39 -30.03 -35.22 Net Cash Inflow / Outflow 9.34 10.52 16.82 4.59 3.51 14.30 0.58 -0.15 -0.46 -0.06 Opening Cash & Equivalents 52.26 41.74 24.92 20.33 16.82 2.52 1.94 2.09 2.55 1.99 Closing Cash & Equivalent 61.60 52.26 41.74 24.92 20.33 16.82 2.52 1.94 2.09 1.93

Description Mar 14 Mar 13
Cash From Operating Activity 58.10 66.85 PBT 54.15 45.48 Adjustment 35.35 31.74 Changes in Working Capital -12.85 -0.53 Cash after chg. in Working capital 76.65 76.69 Interest Paid 0.00 0.00 Tax Paid -16.77 -7.43 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -21.82 -54.00 Net Fixed Assets -19.64 Net Investments 0.00 Others -2.18 Cash from Financing Activity -36.07 -12.55 Net Cash Inflow / Outflow 0.21 0.30 Opening Cash & Equivalents 1.78 1.48 Closing Cash & Equivalent 1.99 1.78

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 52.12 41.39 35.50 29.75 29.21 26.62 25.34 25.18 24.41 21.25 ROA 19.39% 16.94% 13.12% 0.53% 10.01% 6.65% 4.74% 5.71% 5.42% 7.30% ROE 28.92% 24.44% 19.60% 0.86% 17.05% 11.93% 9.11% 11.55% 11.68% 17.02% ROCE 39.70% 34.46% 27.58% 2.80% 20.15% 18.29% 14.40% 16.98% 17.72% 23.29% Fixed Asset Turnover 2.34 2.27 1.92 1.36 1.97 2.01 2.01 2.20 1.70 1.32 Receivable days 18.57 18.54 22.75 43.60 34.13 37.20 44.32 43.64 39.26 36.30 Inventory Days 2.34 3.06 3.85 6.19 4.48 4.04 4.62 4.65 5.32 6.35 Payable days 0.00 0.00 0.00 0.00 51.54 45.21 48.19 52.83 50.40 46.97 Cash Conversion Cycle 20.91 21.60 26.60 49.79 -12.93 -3.97 0.75 -4.54 -5.82 -4.32 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.09 0.28 0.29 0.23 0.26 Interest Cover 41.91 28.38 24.19 2.28 9.14 7.49 4.82 6.16 6.22 7.11

Top Investors:

quant mutual fund - quant small cap fund

emedlife insurance broking services limited

vanaja sundar iyer

citadel research and solutions limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Indraprastha Medical - Quarterly Results
30th Oct 2024, 17:03 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback